tirzepatide and rheumatoid arthritis Concomitant ixekizumab significantly improved psoriatic disease activity and promoted weight reduction versus ixekizumab alone in adults with PsA and obesity or overweight in the TOGETHER-PsA phase 3b trial. Read Obesity drug seen as effective

Watch Part 1 GLP-1s: Overview and Q&A Watch Part 2 GLP-1s: Next Steps This webinar is intended for prescribers

While eating less helps create a calorie deficit, it can also lead to: Muscle loss Fatigue Hair thinning Nutrient deficiencies Constipation Slower metabolism That's why the goal isn't just to eat less

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) New England Journal of Medicine 389(24) 2023PMID: 37952131 NEJM 5 U.S

Normally, your brain produces a counter-signal that mutes that appetite suppression thats where naltrexone comes in

The medication is not approved or intended to be sold, distributed, or reconstituted as a powder for patient use outside of FDA-regulated manufacturing processes

The loophole that keeps Empower operating Compounding pharmacies cannot produce exact copies of commercially available drugs when no shortage exists